Quest Diagnostics Incorporated (DGX) Stock

Quest Diagnostics Incorporated specializes in providing comprehensive diagnostic testing, information, and services both domestically and globally. The company operates a network of laboratories, patient service centers, and mobile health professionals, offering a broad spectrum of diagnostic information services. These services range from routine and advanced clinical testing to anatomic pathology and specialized diagnostic testing under various brands including Quest Diagnostics, AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

In addition to its diagnostic testing services, Quest Diagnostics caters to a diverse customer base that includes patients, healthcare providers, hospitals, independent delivery networks, health plans, employers, and accountable care organizations. The company also extends its offerings to the life insurance industry through risk assessment services. Moreover, Quest Diagnostics leverages robust information technology solutions to support healthcare organizations and clinicians in optimizing patient care and operational efficiencies.

Founded in 1967 and headquartered in Secaucus, New Jersey, Quest Diagnostics has established itself as a leader in the healthcare sector, emphasizing innovation, accuracy, and accessibility in diagnostic testing. Continuously expanding its capabilities and service reach, the company remains committed to enhancing healthcare outcomes and contributing to advancements in medical diagnostics globally.